SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-11.49%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$186M
AUM Growth
+$186M
(-33%)
Cap. Flow
-$63.1M
Cap. Flow
% of AUM
-34.01%
Top 10 Holdings %
Top 10 Hldgs %
37.92%
Holding
70
New
7
Increased
10
Reduced
25
Closed
19
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$5.38M |
| 2 |
Danaher
DHR
|
$4.64M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$3.74M |
| 4 |
Smith & Nephew
SNN
|
$2.84M |
| 5 |
Elanco Animal Health
ELAN
|
$2.64M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$8.69M |
| 2 |
AET
Aetna Inc
AET
|
$7.1M |
| 3 |
Align Technology
ALGN
|
$6.85M |
| 4 |
CELG
Celgene Corp
CELG
|
$4.48M |
| 5 |
Quest Diagnostics
DGX
|
$4.32M |
Sector Composition
| 1 | Healthcare | 90.94% |
| 2 | Energy | 2.02% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Abbott
ABT
$231B
| $8.32M | 4.48% |
115,000
| – | – |
|
2
Boston Scientific
BSX
$156B
| $7.78M | 4.19% |
220,000
-15,000
| -6% | -$530K |
|
|
WCG
3
DELISTED
Wellcare Health Plans, Inc.
WCG
| $7.67M | 4.14% |
32,500
+2,500
| +8% | +$590K |
|
4
Cigna
CI
$80.3B
| $7.6M | 4.09% |
40,000
| – | – |
|
5
Merck
MRK
$210B
| $7.26M | 3.91% |
95,000
-25,000
| -21% | -$1.91M |
|
6
UnitedHealth
UNH
$281B
| $6.98M | 3.76% |
28,000
+3,000
| +12% | +$747K |
|
7
Intuitive Surgical
ISRG
$170B
| $6.47M | 3.48% |
13,500
+3,000
| +29% | +$1.44M |
|
8
Eli Lilly
LLY
$657B
| $6.37M | 3.43% |
55,000
-15,000
| -21% | -$1.74M |
|
9
Biogen
BIIB
$19.4B
| $6.02M | 3.24% |
20,000
+2,500
| +14% | +$752K |
|
10
Elevance Health
ELV
$71.8B
| $5.91M | 3.19% |
22,500
-5,000
| -18% | -$1.31M |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $5.8M | 3.13% |
35,000
| – | – |
|
12
Humana
HUM
$36.5B
| $5.73M | 3.09% |
20,000
-5,300
| -21% | -$1.52M |
|
13
Stryker
SYK
$150B
| $5.49M | 2.96% |
35,000
+5,000
| +17% | +$784K |
|
|
14
SPDR S&P Biotech ETF
XBI
$5.07B
| $5.38M | 2.9% |
+75,000
| New | +$5.38M |
|
15
AstraZeneca
AZN
$248B
| $5.14M | 2.77% |
135,400
+10,400
| +8% | +$395K |
|
16
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.68M | 2.52% |
55,000
| – | – |
|
17
Universal Health Services
UHS
$11.6B
| $4.66M | 2.51% |
40,000
-15,000
| -27% | -$1.75M |
|
|
18
Danaher
DHR
$147B
| $4.64M | 2.5% |
+45,000
| New | +$4.64M |
|
19
Illumina
ILMN
$15.8B
| $4.5M | 2.43% |
15,000
| – | – |
|
20
HCA Healthcare
HCA
$94.5B
| $4.36M | 2.35% |
35,000
-20,000
| -36% | -$2.49M |
|
|
WMGI
21
DELISTED
Wright Medical Group Inc
WMGI
| $4.02M | 2.17% |
147,801
+7,801
| +6% | +$212K |
|
22
Baxter International
BAX
$12.7B
| $3.95M | 2.13% |
60,000
-20,000
| -25% | -$1.32M |
|
23
Qiagen
QGEN
$10.1B
| $3.82M | 2.06% |
110,800
+25,800
| +30% | +$889K |
|
|
LHCG
24
DELISTED
LHC Group LLC
LHCG
| $3.76M | 2.02% |
40,000
+5,000
| +14% | +$469K |
|
|
25
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.74M | 2.01% |
+10,000
| New | +$3.74M |
|